Detalles de la búsqueda
1.
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities.
Gastroenterology
; 162(5): 1456-1475.e1, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101422
2.
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn's Disease.
Clin Gastroenterol Hepatol
; 21(11): 2918-2927.e6, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37004971
3.
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol
; 19(9): 1835-1844.e6, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32798706
4.
Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort.
J Gastroenterol Hepatol
; 36(8): 2067-2075, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33381875
5.
Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, Scotland.
Colorectal Dis
; 23(5): 1175-1183, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33350054
6.
IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology.
Gut
; 68(11): 1953-1960, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31300515
7.
Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease.
Clin Gastroenterol Hepatol
; 17(11): 2269-2276.e4, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772585
8.
Implementation of CT-P13 via a Managed Switch Programme in Crohn's Disease: 12-Month Real-World Outcomes.
Dig Dis Sci
; 64(6): 1660-1667, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30535885
9.
Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis: Analysis of the CONSTRUCT dataset.
J Crohns Colitis
; 18(2): 286-290, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37615649
10.
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort.
United European Gastroenterol J
; 11(2): 179-188, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802176
11.
Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease.
Dig Liver Dis
; 55(8): 1034-1041, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36283944
12.
Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis.
Aliment Pharmacol Ther
; 56(1): 67-76, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35301734
13.
Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis.
Therap Adv Gastroenterol
; 14: 17562848211064004, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987608
14.
The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.
Inflamm Bowel Dis
; 27(4): 451-457, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32572468
15.
Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts.
J Crohns Colitis
; 15(12): 2011-2021, 2021 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089587
16.
Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
Eur J Gastroenterol Hepatol
; 32(1): 32-37, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31567638
17.
Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease.
Frontline Gastroenterol
; 11(2): 117-123, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32133110
18.
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study.
United European Gastroenterol J
; 8(9): 1076-1085, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32807038
19.
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy.
Aliment Pharmacol Ther
; 52(1): 135-142, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32412134
20.
Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission.
Inflamm Bowel Dis
; 25(6): 1036-1043, 2019 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30335139
Resultados
1 -
20
de 20
1
Próxima >
>>